Theriva stockholder meeting fails to achieve quorum, triggering 60-day re-vote cycle

Filed June 5, 2026 · Period ending June 5, 2026 · ~1 min read

Key Changes

• high

  Special meeting on June 5 failed to reach quorum, preventing vote on warrant exercise proposal that would authorize issuance of up to 16.2 million shares—roughly 16% potential dilution remains unresolved.

  Item 8.01 verify on EDGAR →
• high

  Company contractually obligated to hold new stockholder meetings every 60 days until approval obtained or warrants expire, creating ongoing administrative costs and uncertainty.

  Item 8.01 verify on EDGAR →
• medium

  Warrant inducement agreement from October 2025 requires stockholder approval for exercise shares; failure to obtain approval could impact warrant holder relations and company's ability to raise capital.

  Item 8.01 verify on EDGAR →